Synergistic Phytoceutical Compositions

Abstract

Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.

What is claimed is: 
     
         1 . A synergistic phytoceutical composition comprising:
 a) at least two plants or ingredients selected from the group consisting of  Acantopanacis, Ajuga, Codonopsis, Cordyceps, Cornu, Ilex,  L-arginine,  Lepidium, Ocimum, Panax, Pfaffia, Ptychopetalum, Rhaponticum, Rhodiola,  and  Schizandra;      b) plus at least two plants or ingredients selected from the group consisting of  Agaricus, Aloe, Andrographis, Annona, Aralia, Astragalus, Camelia, Coriolus, Echinacea, Ganoderma, Grifola, Hydrastis, Lactoferrin, Lentinus, Lobostemon, Morinda, Petiveria, Polygonum, Radix, Radix, Sutherlandia, Tabebuia, Turnera, Uncaria, Valeriana  and  Vitex;      c) plus at least two plants or ingredients selected from the group consisting of  Angelica, Bupleurum, Cimicifuga, Chitin  fiber,  Chondroitin  sulfate,  Crataegus, Croton, Curcubita, Curcuma, Dioscorea, Equisetum, Eucommia, Fructus, Gentiana, Ginkgo, Glucosamin, Glycyrrhiza, Gynostemma, Harpagophytum, Herba, Hydrocotile, Linum, Minerals, Mumiyo, Opuntia, Picrorhiza,  Plant enzymes,  Ptycopetalum, Pygeum, Rhamnus, Ruscus, Salix, Sargassum, Sena, Serenoa, Silibum, Smilax, Solanum, Tribulus, Ulmus, Urtica, Uva ursi, Vaccinium,  and  Viburnum;      d) together with pharmaceutically acceptable excipients or carriers.   
     
     
         2 . The synergistic phytoceutical composition of  claim 1  further comprising:
 a) at least two plants or ingredients selected from the group consisting of  Acantopanacis senticosus, Ajuga turkestanica, Codonopsis pilosula, Cordyceps sinensis, Cornu Cervi pantrotichum, Ilex paraguariensis,  L-arginine,  Lepidium meyenii, Ocimum sanctum, Panax ginseng, Panax quinquefolius, Pfaffia paniculata, Ptychopetalum olacoides, Rhaponticum carthamoides, Rhodiola rosea, Schizandra chinensis,  and  Ubiquinone  (Coenzyme Q10); 
 b) plus at least two plants or ingredients nutraceuticals selected from the group consisting of  Agaricus blazei, Aloe vera, Andrographis peniculata, Annona muricata, Aralia Mandshurica, Astragalus membranaceus,  Beta 1.3 glucan, Beta 1.6 glucan,  Camelia sinensis, Coriolus versicolor, Echinacea angustifolia, Echinacea purpurea, Ganoderma lucidum, Grifola frandosa, Hydrastis canadensis, Lactoferrin, Lentinus edodes, Lobostemon trigonus, Morinda citrifolia, Petiveria alliacea, Polygonum multiflorum radix, Radix apeoniae alba, Radix polygalae,  Shark Cartilage,  Sutherlandia frutescens, Tabebuia avellanedae, Turnera aphrodisiaca, Uncaria tomentosa, Valeriana officinalis  and  Vitex agnus castus;    
 c) plus at least two plants or ingredients selected from the group consisting of  Angelica sinensis, Bupleurum chinense, Cimicifuga racemosa, Chitin fiber, Chondroitin sulfate, Crataegus oxyacantha, Croton lechleri; Curcubita pepo, Curcuma longa, Dioscorea villosa, Equisetum arvense, Eucommia  bark,  Fructus ligustri lucidum, Fructus lycii, Fulvic acid, Gentiana lutea, Ginkgo biloba, Glucosamin, Glycyrrhiza glabra, Gynostemma, Harpagophytum procumbens, Herba epimedii, Hydrocotile asiatica, Linum usitatissimum,  Minerals,  Mumiyo, Opuntia ficus indica, Picrorhiza kurroa,  Plant enzymes,  Ptycopetalum olacoides, Pygeum africanum, Rhamnus purshiana, Ruscus aculeatus, Salix alba, Sargassum fusiforme, Sena alejandrina, Serenoa repens, Silibum marianum, Smilax china, Solanum nigrum, Tribulus terrestris, Ulmus fulva, Urtica dioica, Uva ursi, Vaccinium myrtillus, Viburnum  spp and Vitamins. 
 
     
     
         3 . The phytoceutical composition of  claim 1 , comprising at least 6 plants or extracts or active ingredients derived from each of the following plants:  Ginkgo, Vaccinium, Angelica, Crataegus, Hydrocotyle, Ruscus, Croton, Echinacea, Eleutherococcus, Ganoderma, Grifola, Hydrastis, Panax, Pfaffia, Rhaponticum, Rhodiola, Tabebuia, Panax, Uncaria, Petiveria,  and  Sutherlandia,  together with pharmaceutically acceptable excipients. 
     
     
         4 . The phytoceutical composition of  claim 3 , further comprising at least 6 plants selected from  Ginkgo biloba, Vaccinium myrtillus, Angelica sinensis, Crataegus oxyacantha, Hydrocotyle asiatica, Ruscus aculeatus, Croton lechleri, Echinacea purpurea, Echinacea angustifolia, Eleutherococcus senticosus, Ganoderma lucidum, Grifola frondosa, Hydrastis canadensis, Panax ginseng, Pfaffia paniculada, Rhaponticum carthamoides, Rhodiola rosea, Tabebuia avellanedae, Panax quinquefolius, Uncaria tomentosa, Petiveria alliacea,  and  Sutherlandia frutescens.    
     
     
         5 . (canceled) 
     
     
         6 . The phytoceutical composition of  claim 1 , comprising at least 6 plants or extracts or active ingredients derived from each of the following plants:  Rhodiola, Vitex, Echinacea, Astragalus, Ganoderma, Uncaria, Grifola, Dioscorea, Tabebuia, Pfaffia, Panax, Hydrocotile asiatica,  together with pharmaceutically acceptable excipients. 
     
     
         7 . The phytoceutical composition of  claim 6  further comprising at least 6 plants selected from  Rhodiola rosea, Vitex agnus castus, Echinacea angustifolia, Echinacea angustifolia radix, Echinacea purpurea, Echinacea purpurea radix, Astraglus membranaceous, Uncaria tomentosa, Grifola frondosa, Dioscorea villosa, Tabebuia avellanedae, Pfaffia paniculata, Panax quinquefolius, Hydrocotile asiatica asiatica.    
     
     
         8 . (canceled) 
     
     
         9 . The phytoceutical composition of  claim 1 , comprising at least 6 plants or extracts or active ingredients derived from each of the following plants:  Rhaponticum, Rhodiola, Szchisandra, Angelica, Astragalus, Echinacea, Ganoderma, Hydrastism, Lepidium, Panax, Silibum, Tabebuia, Uncaria, Equisetum, Hydrocotile, Picrorhiza, Smilax,  and  Vaccinium,  plus shark cartilage and Fulvic Acid, together with pharmaceutically acceptable excipients. 
     
     
         10 . The phytoceutical composition of  claim 9 , further comprising at least 6 plants selected from  Rhaponticum carthamoides, Rhodiola rosea, Szchisandra chinensis, Angelica sinensis, Astragalus membranaceus, Echinacea angustifolia, Echinacea angustifolia radix, Echinacea purpurea, Echinacea purpurea radix, Ganoderma lucidum, Hydrastis canadensis, Lepidium meyenii, Panax ginseng, Silibum marianum, Tabebuia avellanedae, Uncaria tomentosa, Equisetum arvense, Hydrocotile asiatica, Picrorhiza kurroa, Smilax officinalis,  and  Vaccinium mirtyllus.    
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . A method of treating disease comprising:
 administering an effective amount of the composition of  claim 1  to a patient sufficient to alleviate said disease.   
     
     
         14 . The method of  claim 13 , wherein the disease is a circulatory disease, a female endocrine disorder, or a skin disorder. 
     
     
         15 . (canceled) 
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . The synergistic phytoceutical composition of  claim 1 , comprising at least 3 plants from the plants recited in a), b), and c). 
     
     
         19 . The synergistic phytoceutical composition of  claim 1 , comprising at least 4 plants from the plants recited in a), b), and c). 
     
     
         20 . A method of preparing a synergistic phytoceutical composition comprising:
 a) selecting at least three plants containing active ingredients associated with ATP synthesis (Energy plants);   b) selecting at least three plants containing active ingredients that regulate the neuroendocrine system, immunological system or cellular processes (Bio-Intelligence plants);   c) selecting at least three plants containing active ingredients that relate to the structure and function of specific organs (Organization plants); and   d) combining said plants or plant portions or extracts thereof and adding a pharmaceutically acceptable excipient.   
     
     
         21 . The method of  claim 20 , wherein the Energy plants, Bio-Intelligence plants and Organization plants are selected from those listed in Table 8. 
     
     
         22 . A composition prepared by the method of  claim 20 .